A carregar...
Potassium-Binding Agents for the Clinical Management of Hyperkalemia
Use of sodium polystyrene sulfonate (SPS) dominates the long-term treatment of hyperkalemia, but two new agents, sodium zirconium cyclosilicate and the recently FDA-approved patiromer, may offer potential advantages compared with SPS.
Na minha lista:
Publicado no: | P T |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MediMedia USA, Inc.
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699486/ https://ncbi.nlm.nih.gov/pubmed/26765867 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|